Biomarker Identification and Quantification by Mass Spectrometry

Biomarker Identification and Quantification by Mass Spectrometry

Bioanalytical & Data

Information

Sensitive, precise, and accurate, mass spectrometry is used for multiple applications, ranging from large-scale proteomic analysis to identify proteins (e.g. Biomarkers, Targets and/or Neo-Epitope), to quantification of biomarkers in support of clinical trials and diagnostic development. Caprion offers two platforms: a discovery platform which uses unbiased LC-MS/MS, and a targeted platform which uses Multiple Reaction Monitoring (MRM). For more information: https://www.caprion.com/en/index.php
Caprion BiosciencesCaprion - HistoGeneX is a leading provider of specialized precision medicine services to the biopharmaceutical industry including flow and mass cytometry immune monitoring, quantitative mass spectrometry, molecular profiling, as well as quantitative immunohistochemistry. Leveraging its integrated platforms, Caprion-HistoGeneX supports the entire drug development cycle, from discovery to clinical trials. The company operates globally with laboratories located in Canada, USA, Belgium, UK, Australia, and China.

Log in